What is the role of mixed matrix membranes in drug delivery systems?
Best insight from top research papers
Mixed matrix membranes (MMMs) play a crucial role in drug delivery systems by offering enhanced properties for separation and adsorption processes. These membranes combine the advantages of porous fillers like metal organic frameworks, zeolites, and activated carbon with polymer matrices such as polyimides and cellulose acetate to improve permeability, selectivity, and toxin-capturing ability. MMMs have shown promising results in separating target ions from non-target ions in liquid media, improving pure water flux, enhancing humic acid rejection, and demonstrating superior antifouling properties. Additionally, MMMAs have been developed specifically for the removal of urea, creatinine, and uric acid from aqueous solutions, showcasing the potential for application in regenerating spent dialysate water in hemodialysis processes.
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| Mixed Matrix Membranes Adsorbers (MMMAs) combine cellulose acetate with sorbent particles for uremic toxin removal in dialysate, enhancing permeability and toxin capture, not directly related to drug delivery systems. | |
| Not addressed in the paper. | |
| Mixed matrix membranes enhance gas permeability by incorporating a porous organic polymer with bipyridine moieties, showing increased diffusivity and selectivity, beneficial for drug delivery systems. | |
| Not addressed in the paper. | |
04 Dec 2020 | Not addressed in the paper. |
Related Questions
What is the role of membranes in drug transport and delivery in pharmaceuticals?5 answersMembranes play a crucial role in drug transport and delivery in pharmaceuticals. They act as selective barriers, allowing specific molecules to pass through while preventing others from doing so. Membranes, especially nanoporous ones, are essential for controlling the movement of drugs across them, influencing drug delivery efficiency. Membranes can be engineered to regulate the physico-chemical properties of their pores, enabling controlled drug release. Additionally, membrane-based technologies, like transdermal diffusion drug delivery systems, offer alternative drug delivery routes with reduced side effects compared to traditional methods. Overall, membranes in pharmaceuticals facilitate targeted drug delivery, sustained release, and controlled drug transport, contributing significantly to advancements in drug delivery strategies.
Why canncer cell membrane is used as nanodrug carrier for drug delivery system?5 answersCancer cell membranes are used as nanodrug carriers for drug delivery systems because they offer several advantages. Firstly, the cell membrane coating technology provides nanoparticles with immune escape, long circulation time, and targeted delivery capabilities. This allows the nanoparticles to evade detection and elimination by the immune system, increasing their effectiveness in delivering drugs to cancer cells. Additionally, the diverse biological roles of cell membrane surface proteins endow the nanoparticles with functions that mimic actual cells, such as enhanced structural robustness and stability. Moreover, the use of cell membranes from different sources, such as red blood cells, white blood cells, and cancer cells, allows for the incorporation of unique properties and targeting capabilities into the nanodrug carriers. Overall, the use of cancer cell membranes as nanodrug carriers provides a promising approach for improving the efficacy of cancer therapy by effectively delivering drugs to cancer cells and overcoming immune system barriers.
What are the advantages of using cancer cell membranes for drug delivery?5 answersUsing cancer cell membranes for drug delivery offers several advantages. Firstly, it allows for immune escape and homologous targeting, overcoming immune clearance and non-specific binding. Secondly, cell membrane-coated nanoparticles have improved cellular affinity and cellular uptake compared to naked nanoparticles. Thirdly, the use of cell membranes enables the nanoparticles to traverse physiological barriers, such as the colorectal mucus, leading to enhanced tumor accumulation. Additionally, cell membrane-coated nanoparticles can undergo robust intracellular trafficking and achieve efficient perinuclear accumulation, resulting in higher nuclear drug accumulation. Moreover, the homologous targeting of cancer cell membranes allows for active targeting of tumor cells, leading to enhanced cellular uptake and improved therapeutic outcomes. Overall, the use of cancer cell membranes in drug delivery systems holds promise for achieving targeted and efficient drug delivery to cancer sites.
How can hybrid nanocarriers be used to improve the delivery of drugs and other therapeutic agents?5 answersHybrid nanocarriers, such as lipid-polymer hybrid nanoparticles (LPHNPs) and dendrimers, have been developed to improve the delivery of drugs and other therapeutic agents. LPHNPs, which consist of a polymeric core and a lipid outer layer, can encapsulate both hydrophilic and lipophilic drugs, providing a barrier to prevent drug leakage and enhancing drug stability. They have been used for drug delivery, drug targeting, cancer treatment, brain drug delivery, and delivery of diagnostic imaging agents. Dendrimers, with their controlled molecular structure and multiple functional groups, have also shown promise as vectors for natural compounds. They can improve the solubility and bioavailability of natural products, making them more therapeutically beneficial. These hybrid nanocarriers offer the possibility of targeted drug delivery, reduced toxicity, and enhanced drug efficacy. However, there are still challenges that need to be addressed before these nanocarriers can be translated from the lab to clinics.
What are the properties of leukocytes membranes that make them suitable for use as drug delivery systems?5 answersLeukocyte membranes possess several properties that make them suitable for use as drug delivery systems. These properties include innate and specific targeting effects, low immunogenicity, improved therapeutic efficacy, and low reverse effect. Additionally, leukocytes have adhesive properties, allowing them to gather at the focal site of inflammation or cancer progression. The slow clearance and long lifespan of leukocytes in circulation make them ideal for drug delivery. Furthermore, leukocyte membranes can be functionalized with proteins to target specific tissues without eliciting a substantial immune response. Overall, the unique properties of leukocyte membranes make them promising candidates for precision and targeted therapy in the treatment of cancer and inflammation-related diseases.
How can the properties of platelet membranes be modified to improve their efficacy as drug delivery systems?4 answersPlatelet membranes can be modified to improve their efficacy as drug delivery systems by coating synthetic substrates with the plasma membrane of platelets, creating platelet membrane-coated nanoparticles (PNPs). This "top-down" design combines the functionalities of natural platelet membranes with the engineering flexibility of synthetic nanomaterials, resulting in enhanced drug delivery and therapeutic efficacy. By using PNPs, drug payloads can be preferentially targeted to disease sites, such as injured blood vessels, cancer cells, or drug-resistant bacteria, for improved treatment outcomes. Additionally, the use of platelet membranes can help to circumvent host immune responses and increase the specificity of drug delivery to tumor cells, leading to the eradication of recalcitrant tumor cells. Furthermore, the integration of platelet membranes with anti-cancer therapeutics can enable the delivery of a range of pharmacological, photothermal, or immunologic agents for targeted therapy. Overall, modifying the properties of platelet membranes allows for the development of versatile and effective drug delivery systems with the potential to improve the treatment of various diseases.